Breast cancer is more commonly associated with women more than with men, affecting approximately one in eight women in their lifetimes.
However, men can still be diagnosed with breast cancer, albeit in far rarer circumstances.
While boys do not develop breasts like girls do during puberty, they still have a small amount of breast tissue behind the nipples where breast cancer can develop, Macmillan Cancer Support explains.
Evgen Pharma (LON:EVG) is a clinical stage drug development company whose lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. The Company’s core technology is Sulforadex®, a method for synthesising and stabilising the naturally occurring compound sulforaphane and novel proprietary analogues based on sulforaphane. The lead product, SFX-01, is a patented composition of synthetic sulforaphane and alpha-cyclodextrin.